AMBER FULLINGTON: Open Payments
NPI 1164020822 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$121 in 7 payments from 5 companies in 2025. Trend: 2023 $97 · 2024 $15 · 2025 $121
Food & beverage: $121
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Genentech USA, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Resmed Corp | 1 | $18 |
| Viatris Specialty LLC | 1 | $15 |
Products named: FASENRA, Xolair, GLASSIA, AIRSENSE, YUPELRI.
Industry payments across MO — which companies pay providers there.
